Detalhe da pesquisa
1.
Isolation of a novel missense mutation in insulin receptor as a spontaneous revertant in ImpL2 mutants in Drosophila.
Development
; 150(1)2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36504086
2.
Ultrasound-based steatosis grading system using 2D-attenuation imaging: an individual patient data meta-analysis with external validation.
Hepatology
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652643
3.
Erebosis, a new cell death mechanism during homeostatic turnover of gut enterocytes.
PLoS Biol
; 20(4): e3001586, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468130
4.
The polyol pathway is an evolutionarily conserved system for sensing glucose uptake.
PLoS Biol
; 20(6): e3001678, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687590
5.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
6.
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver Int
; 44(1): 113-124, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789669
7.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517286
8.
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res
; 54(4): 382-391, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983642
9.
Prevalence of bleeding events in real-world Japanese registry for Percutaneous Ventricular Assist Device.
J Artif Organs
; 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396197
10.
Sima, a Drosophila homolog of HIF-1α, in fat body tissue inhibits larval body growth by inducing Tribbles gene expression.
Genes Cells
; 27(2): 145-151, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918430
11.
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Oncology
; 101(4): 270-282, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455517
12.
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
Oncology
; 101(10): 624-633, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307798
13.
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Oncology
; 101(9): 542-552, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552968
14.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657420
15.
Short-Term Outcomes of Impella Support in Japanese Patients With Cardiogenic Shock Due to Acute Myocardial Infarctionã- Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD).
Circ J
; 87(5): 588-597, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682787
16.
Novel Scoring System to Risk Stratify Patients Receiving Durable Left Ventricular Assist Device From J-MACS Registry Data.
Circ J
; 87(8): 1103-1111, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258218
17.
Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization.
Cell
; 135(1): 161-73, 2008 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-18854163
18.
Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
Hepatol Res
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015179
19.
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Hepatol Res
; 53(8): 737-748, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020416
20.
Geriatric nutritional risk index as an easy-to-use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Hepatol Res
; 53(10): 1031-1042, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306040